Literature DB >> 21048510

Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO).

Sofie Vandenbroeck1, Sabina De Geest, Fabienne Dobbels, Steffen Fieuws, Ingeborg Stalmans, Thierry Zeyen.   

Abstract

PURPOSE: This study aimed to investigate (1) the prevalence of nonadherence with eye drop treatment; (2) selected correlates of nonadherence at the patient and health-care organization level; and (3) the diagnostic value of the ophthalmologists' ratings, using patients' self-reports as standard.
METHODS: This cross-sectional multicenter survey used questionnaires for ophthalmologists and their patients to assess self-reported nonadherence and its correlates. One item, using a 4-point scale [never (ie, adherent) to daily], asked the patients whether they had forgotten to administer eye drops during the past 2 weeks. Ophthalmologists rated their patients as adherent or nonadherent. Nonadherence was also determined by combined methods, whereby either could indicate nonadherence. Given the nested structure of the data, multilevel modeling was used to investigate self-reported nonadherence-correlates. Diagnostic values of ophthalmologists' report were calculated.
RESULTS: Of 663 patients (48% female, 44% >69 years), nonadherence was indicated in 39.2% (n=260) through self-reporting, 2.1% (n=14) through ophthalmologists' ratings, and 40% (n=266) through combined measures. The multivariable, multilevel model showed following significant nonadherence-correlates: Male sex (P=0.01), younger age (P=0.027), and higher-dose frequency (P=0.001). No significant correlation with treating ophthalmologist (P=0.21) could be seen. Yet, the patients visiting their ophthalmologists at least every 3 months were less nonadherent than patients with fewer consultations (P=0.01). The ophthalmologists' report showed a sensitivity and specificity of 3% and 98.5%, respectively.
CONCLUSIONS: The prevalence of self-reported nonadherence was congruent with literature. The patients visiting their ophthalmologists at least every 3 months have a lower risk of nonadherence. Ophthalmologist report is an insensitive method for detecting nonadherence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21048510     DOI: 10.1097/IJG.0b013e3181f7b10e

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  12 in total

1.  Development and validation of a predictive model for nonadherence with once-daily glaucoma medications.

Authors:  Dolly S Chang; David S Friedman; Travis Frazier; Ryan Plyler; Michael V Boland
Journal:  Ophthalmology       Date:  2013-03-28       Impact factor: 12.079

2.  Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.

Authors:  John D Sheppard; Melissa M Toyos; John H Kempen; Paramjit Kaur; C Stephen Foster
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-06       Impact factor: 4.799

3.  Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors.

Authors:  Robyn Sayner; Delesha M Carpenter; Susan J Blalock; Alan L Robin; Kelly W Muir; Mary Elizabeth Hartnett; Annette L Giangiacomo; Gail Tudor; Betsy Sleath
Journal:  Clin Ther       Date:  2015-07-09       Impact factor: 3.393

4.  Comparing Combination Drop Therapy to a Standard Drop Regimen After Routine Cataract Surgery.

Authors:  Kerry D Solomon; Helga P Sandoval; Richard Potvin
Journal:  Clin Ophthalmol       Date:  2020-07-10

5.  Efficacy of montelukast in preventing seasonal recurrence of vernal keratoconjunctivitis in children.

Authors:  Apurva Hardas; Neera Singh; Amrita Mohanty; Srikant Kumar Sahu
Journal:  Eye (Lond)       Date:  2021-05-04       Impact factor: 4.456

6.  Induced pluripotent stem cells restore function in a human cell loss model of open-angle glaucoma.

Authors:  Diala W Abu-Hassan; Xinbo Li; Eileen I Ryan; Ted S Acott; Mary J Kelley
Journal:  Stem Cells       Date:  2015-03       Impact factor: 6.277

7.  Transzonular vitreous injection vs a single drop compounded topical pharmaceutical regimen after cataract surgery.

Authors:  Bret L Fisher; Rick Potvin
Journal:  Clin Ophthalmol       Date:  2016-07-18

8.  Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy.

Authors:  Yuka Hasebe; Kenji Kashiwagi; Toyoaki Tsumura; Yasuyuki Suzuki; Keiji Yoshikawa; Hirotaka Suzumura; Toshine Maeda; Ryuji Takeda; Hitomi Saito; Makoto Araie
Journal:  Patient Prefer Adherence       Date:  2018-08-27       Impact factor: 2.711

Review 9.  Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus.

Authors:  Quang H Nguyen
Journal:  Patient Prefer Adherence       Date:  2014-06-12       Impact factor: 2.711

10.  Treating allergic conjunctivitis: A once-daily medication that provides 24-hour symptom relief.

Authors:  Warner Carr; Jack Schaeffer; Eric Donnenfeld
Journal:  Allergy Rhinol (Providence)       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.